CClinicalTrials.gg
CompletedNCT02152475Updated Jun 3, 2014

Photodynamic Therapy (PDT) for Oral Disinfection

A Phase 1 interventional study of mouthwash with curcumin and blue LED illumination in Healthy, sponsored by University of Sao Paulo. Completed at 1 site in Brazil. Open to participants aged 20 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-06-03.

Sponsored by University of Sao Paulo · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 35 Years
Sex
All
01

Study summary

Photodynamic therapy (PDT) is a technique used for the oral disinfection. In dentistry, PDT for microbial inactivation may reduces both dental plaque and risk of developing caries as well as contributes to treat gingivitis, periodontitis, peri-implantitis and endodontic diseases. The investigators hypothesis was that PDT with blue light and curcumin promotes oral disinfection during 2 hours after treatment.

Read the detailed description

PDT uses a non-toxic drug that is activated by exposure to light in the presence of oxygen. The excited state this drug transfers energy or electrons to ground state molecular oxygen producing cytotoxic effects on cell. There are productions of reactive oxygen species (ROS) and disrupts several of the cell's functions. This results in bacterial disinfection. In order to perform the PDT on the oral cavity, a device based on blue LED with transparent acrylic diffuser tip and cylindrical shape was developed.

02

Conditions studied

  • Healthy

Keywords

  • Blue-LED
  • Curcumin
  • PDT
  • Oral disinfection
03

In context

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,005 studies on the registry; 90 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • non-users of any antibiotic therapy
  • those who do not perform any oral hygiene, such as flossing, brushing and antiseptic mouthwash
  • those who performed 12-hour fasting prior the treatment and measurements

Exclusion criteria

Exclusion Criteria:

  • oral cancer
  • smoking habits
  • pregnancy
  • patients with partial or total dentures
  • orthodontic brackets users
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    PDT with blue light and curcumin

    PDT treatment was performed with light and curcumin.The irradiation parameters were: blue-light emitting diode (LED) illumination (455±30 nm), 400 mW of average optical power, 5 min of application, illumination area of 0.666 cm2, 600 mW/cm2 of intensity and 120 J/cm2 of fluence. The curcumin concentration of 30 mg/L was used.

    Drug: mouthwash with curcumin · Device: blue LED illumination

  • Active comparator
    Curcumin

    The curcumin concentration of 30 mg/L was used.

    Drug: mouthwash with curcumin

  • Active comparator
    Blue light

    The irradiation parameters were: blue-light emitting diode (LED) illumination (455±30 nm), 400 mW of average optical power, 5 min of application, illumination area of 0.666 cm2, 600 mW/cm2 of intensity and 120 J/cm2 of fluence.

    Device: blue LED illumination

Interventions

  • Drugmouthwash with curcumin

    Mouthwash with 20 ml of curcumin solution for 5 minutes

  • Deviceblue LED illumination

    Oral cavity was illuminated with blue light for 5 minutes

06

What researchers measure

Primary outcomes

  1. Microbiological analysis by the total number of colony-forming units (CFU).

    Two saliva samples from each volunteer were collected. The saliva samples underwent serial dilutions and 100-microliters aliquots were plated on brain heart infusion agar plates (in duplicate) and then incubated under microaerophilic conditions. After incubation, the total number of colony-forming units (CFU) was determined.

    Time frame: Two hours

07

Study locations

1 site
  • Fernanda Rossi Paolillo
    São Carlos, São Paulo 970, Brazil
08

References and documents

Publications

  • Araujo NC, Fontana CR, Gerbi ME, Bagnato VS. Overall-mouth disinfection by photodynamic therapy using curcumin. Photomed Laser Surg. 2012 Feb;30(2):96-101. doi: 10.1089/pho.2011.3053. Epub 2012 Jan 6. PubMed 22224655 ↗
  • Araujo NC, Fontana CR, Bagnato VS, Gerbi ME. Photodynamic antimicrobial therapy of curcumin in biofilms and carious dentine. Lasers Med Sci. 2014 Mar;29(2):629-35. doi: 10.1007/s10103-013-1369-3. Epub 2013 Jun 23. PubMed 23793414 ↗
  • Gursoy H, Ozcakir-Tomruk C, Tanalp J, Yilmaz S. Photodynamic therapy in dentistry: a literature review. Clin Oral Investig. 2013 May;17(4):1113-25. doi: 10.1007/s00784-012-0845-7. Epub 2012 Sep 27. PubMed 23015026 ↗
  • Fontana CR, Lerman MA, Patel N, Grecco C, Costa CA, Amiji MM, Bagnato VS, Soukos NS. Safety assessment of oral photodynamic therapy in rats. Lasers Med Sci. 2013 Feb;28(2):479-86. doi: 10.1007/s10103-012-1091-6. Epub 2012 Mar 31. PubMed 22467011 ↗
  • Soukos NS, Som S, Abernethy AD, Ruggiero K, Dunham J, Lee C, Doukas AG, Goodson JM. Phototargeting oral black-pigmented bacteria. Antimicrob Agents Chemother. 2005 Apr;49(4):1391-6. doi: 10.1128/AAC.49.4.1391-1396.2005. PubMed 15793117 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02152475
Lead sponsor
University of Sao Paulo
Collaborators
Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo
Responsible party
Fernanda Rossi Paolillo (Ph.D, University of Sao Paulo) — Principal investigator
First posted
Jun 2, 2014
Start date
May 2013
Primary completion
Nov 2013
Completion
Nov 2013
Last update
Jun 3, 2014

Study contacts

Vanderlei S Bagnato, Ph.D
study director · Physics Institute of São Carlos (IFSC), University of São Paulo (USP)
Diego PV Leite, DDS
principal investigator · Physics Institute of São Carlos (IFSC), University of São Paulo (USP)
Fernanda R Paolillo, Ph.D
principal investigator · Physics Institute of São Carlos (IFSC), University of São Paulo (USP)
Carla R Fontana, Ph.D
principal investigator · Univ Estadual Paulista (UNESP)
Thiago Parmesano, Student
study chair · Physics Institute of São Carlos (IFSC), University of São Paulo (USP)

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion